Skip to main content
Europlasma logo

Europlasma — Investor Relations & Filings

Ticker · ALEUP ISIN · FR001400CF13 LEI · 969500WYVNHBV1ABQ250 Euronext Growth Water supply; sewerage, waste management and remediation activities
Open in API
Filings indexed 504 across all filing types
Latest filing 2026-05-12 Regulatory Filings
Country FR France
Listing Euronext Growth ALEUP

About Europlasma

https://www.europlasma.com/en/

Europlasma is a company specializing in clean technology and energy solutions. Its core activities focus on the research, engineering, and application of plasma solutions for industrial purposes, particularly for the treatment of hazardous waste and gas. The company provides services for the destruction and valorization of asbestos waste. In the decarbonization sector, Europlasma transforms waste into Solid Recovered Fuel (SRF). Additionally, the company operates an industrial division that manufactures hollow bodies and anodized sheets for capacitors.

Recent filings

Filing Released Lang Actions
EUROPLASMA: Information relative au nombre total de droits de vote et d’actions composant le capital au 30 avril 2026
Regulatory Filings Classification · 85% confidence The document is a press release disclosing the total number of shares and voting rights as of April 30, 2026, in accordance with French regulatory requirements (articles L.233-8 II of the French Commercial Code and AMF rules). It does not announce a shareholder vote result, insider transaction, new share issue, dividend, or any detailed financial report. It is a routine regulatory announcement of capital and voting rights figures, fitting the fallback category for miscellaneous compliance filings. Therefore, it should be classified as a Regulatory Filing (RNS).
2026-05-12 French
EUROPLASMA: Information relative au nombre total de droits de vote et dactions composant le capital au 30 avril 2026
Regulatory Filings Classification · 75% confidence The document is a short regulatory news release under French AMF rules (articles L.233-8 II and 223-16) disclosing the total number of shares and voting rights as of April 30, 2026. It is not presenting financial results, not an AGM vote result, nor a report publication announcement–it is the mandatory periodic disclosure itself. This fits the catch-all Regulatory Filings category (RNS).
2026-05-12 French
EUROPLASMA: Mise en place d’un nouveau financement obligataire et report de la publication des états financiers 2025 du Groupe
Capital/Financing Update Classification · 95% confidence The document is a press release dated April 30, 2026, from Europlasma announcing the establishment of a new bond financing program (OCABSA) with a nominal maximum amount of 45 million euros over 36 months. It details the terms of the financing, the potential dilution impact on shareholders, and the context and use of funds. It also announces a delay in the publication of the 2025 financial statements due to ongoing audit work and structural operations during the fiscal year. The document includes warnings about the risks of dilution and references to previous communications and financial reports. The document is primarily an announcement of a capital raising/financing activity and related operational updates, not the financial report itself. It is not a full annual or interim report, nor a management discussion or earnings release. It is not a regulatory certification or a voting result announcement. The document is lengthy (15,000 characters) and detailed but is clearly a financing update and related market communication. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2026-04-30 French
EUROPLASMA: Mise en place dun nouveau financement obligataire et report de la publication des etats financiers 2025 du Groupe
Capital/Financing Update Classification · 95% confidence The document is a regulatory news announcement dated April 30, 2026, from Europlasma. It details the establishment of a new bond financing (OCABSA) with a maximum nominal amount of 45 million euros over 36 months, including potential dilution effects on shareholders. It also announces a delay in the publication of the group's 2025 financial statements due to ongoing audit work and structural operations during the fiscal year. The document includes detailed information about the financing terms, the context and use of funds, and references to previous communications and annual reports. However, it does not contain the actual financial statements or substantive financial data of the 2025 fiscal year. Instead, it is an announcement about the financing arrangement and the postponement of the financial report publication. The document is lengthy (15,000 characters) but serves as a regulatory announcement rather than the financial report itself. Therefore, it fits best under the category of Capital/Financing Update (CAP) because it primarily focuses on the new financing arrangement and its implications, with a secondary note on the delay of the financial report publication. It is not a full Annual Report (10-K), Interim Report (IR), or Earnings Release (ER), nor is it a Report Publication Announcement (RPA) since it does not merely announce the availability of a report but provides substantive details on the financing. Hence, the classification is CAP with high confidence.
2026-04-30 French
EUROPLASMA: Tirage de 400 obligations convertibles en actions nouvelles pour un montant nominal de 2M€
Capital/Financing Update Classification · 85% confidence The document is a detailed press release announcing the draw of two tranches of convertible bonds (400 OCA) for €2M, including legal framework, terms, risks, and dilution impact. This is a financing/activity update regarding capital structure changes rather than an annual or interim report, earnings release, or governance filing. It fits the definition of a Capital/Financing Update.
2026-04-24 French
EUROPLASMA: Tirage de 400 obligations convertibles en actions nouvelles pour un montant nominal de 2M
Capital/Financing Update Classification · 82% confidence The document is a press release detailing the drawdown of two tranches of convertible bonds (“obligations convertibles”) for a nominal €2 million under an existing bond issue, including legal and risk disclosures. It is not an AGM material, full financial report, or regulatory notice of a report publication. It is an update on the company’s financing activities and capital-structure transaction. Therefore, it falls under Capital/Financing Update (CAP).
2026-04-24 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.